April 2018 - Page 5 of 8

Denny’s Share Buybacks Support Uptrend

Denny’s Corp (NASDAQ:DENN) shares hit the 52-week high of $16 a share yesterday, amid investors increasing confidence in its future fundamentals and cash generation potential. DENN stock rose 18% since the start of this year, ... [Read]

Verastem Inc Shares Rise – New Drug Application Accepted by FDA

Apr 10 Nicky Toor

Shares of the biopharmaceutical company Verastem Inc. (NASDAQ:VSTM) were on the rise on Monday after the company announced that the United States Food and Drug Administration (FDA) had accepted their New Drug Application (NDA) for ... [Read]

High Hampton Retains Marc J. Ross as U.S. Cannabis Legal Counsel

Apr 10 High Hampton Holdings

Toronto, Ontario – High Hampton Holdings Corp. (CSE:HC) (FRA: 0HCN)(“High Hampton” or the “Company“) today announced that it has retained Marc J. Ross, Esq., of Sichenzia Ross Ference Kesner LLP, as the Company’s U.S. Cannabis ... [Read]

Freshpet Stock: Analysts See Upside – Here’s Why

Apr 9 Siraj Sarwar

Freshpet (NASDAQ:FRPT) stock posted solid returns for investors last year and analysts see further upside in FRPT stock this year. FRPT stock rose 64% over the previous twelve months to $18 at present. Analysts, however, think ... [Read]

Supervalu Activists Seek Asset Sale Despite Increasing Revenues

Apr 9 Siraj Sarwar

SuperValu (NYSE:SVU) shares lost 80% of their value in the last three years due to increasing market competition in the grocery stores industry. SVU revenues fell from $17 billion in 2013 to $12 billion in ... [Read]

Turtle Beach Corporation Shares Up Over 35%

Apr 9 Nicky Toor

Shares of the San Diego-based gaming headset and audio accessory company, Turtle Beach Corporation (Nasdaq:HEAR) have gone up by over 35% today. The jump in share value comes after the company released its preliminary first-quarter ... [Read]

Shares of Menlo Therapeutics Plummet By 70%

Apr 9 Nicky Toor

Shares of the biopharmaceutical company Menlo Therapeutics Inc. (Nasdaq:MNLO) have plummeted by nearly 70%. The loss of share value is due to the company releasing the results of their Phase 2 Trial of ‘Serlopitant’ for ... [Read]

EyeGate Pharmaceuticals – Stock Up Nearly 25%

Apr 6 Nicky Toor

Shares of Massachusetts-based EyeGate Pharmaceuticals (Nasdaq:EYEG) have gone up nearly 25% after the company announced the enrollment confirmation of the Phase 3 Clinical Study of EGP-437 in Anterior Uveitis. The trial is meant “to assess ... [Read]

Is Net Element International Stock Set for A Sustainable Bull Run?

Apr 6 Siraj Sarwar

Net Element International (NASDAQ:NETE) shares are on the roller coaster since the start of this year, amid few critical changes in its management and other market reports. The company’s stock jumped more than 30% in ... [Read]

LongFin: Short Selling Caused the Slump, CEO Says

Apr 6 Siraj Sarwar

LongFin Corporation (NASDAQ:LFIN) stock price started crashing following the removal of its name from Russell Indexes, amid the failure to meet the minimum 5% free float requirement. The selloff intensified last week after the company ... [Read]